Regulated Information

Period

Filter by

Reset

Showing: 1 – 05 of 157 Regulated Information

Show

Sort

Ipsen - Monthly information relative to the total number of voting rights and shares composing the share capital

06 February 2024

Ipsen – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital

Phase III trial data investigating Cabometyx® in combination with immunotherapy to be presented at ASCO GU 2024

22 January 2024

Phase III trial data investigating Cabometyx® in combination with immunotherapy to be presented at ASCO GU 2024

PARIS, FRANCE, 22 January 2024 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today new data to be presented for Cabometyx® (cabozantinib) in combination with immunotherapy across indications at the upcoming American Society of Clinical Oncology Genitourinary Symposium (ASCO GU) taking…